Adbiotech Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $8.86M

Adbiotech General Information

Description

Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Contact Information

Website
www.adbiotech.com
Formerly Known As
Feed Bank
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 39, Geodudanji 1-gil
  • Dongnae-myeon
  • Chuncheon, Gangwon
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
OQ BioM
Vertical(s)
Life Sciences
Corporate Office
  • 39, Geodudanji 1-gil
  • Dongnae-myeon
  • Chuncheon, Gangwon
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adbiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. PIPE 04-Jun-2026 $8.86M Completed Generating Revenue
10. PIPE 29-Aug-2025 Completed Generating Revenue
9. Merger/Acquisition 10-Jul-2025 Completed Generating Revenue
8. Secondary Transaction - Private 05-Jun-2025 Completed Generating Revenue
7. PIPE 09-Jul-2020 Completed Generating Revenue
6. PIPE 31-Dec-2019 Completed Generating Revenue
5. IPO 24-Dec-2019 Completed Generating Revenue
4. Later Stage VC 30-Mar-2019 Completed Startup
3. Later Stage VC 13-Jul-2018 $2.69M $6.18M Completed Startup
2. Later Stage VC 01-Dec-2016 $2.39M $3.49M Completed Startup
To view Adbiotech’s complete valuation and funding history, request access »

Adbiotech Patents

  • 26

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Adbiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024111697-A1 Method for preparing single domain vhh antibody for prevention or treatment of digestive disorder in calves Inactive 22-Nov-2022
WO-2023140401-A1 Method for producing single domain vhh antibody for prevention or treatment of early mortality syndrome in shrimp Inactive 19-Jan-2022
WO-2021100992-A1 Method for preparing anti-helicobacter pylori egg yolk antibody Inactive 18-Nov-2019
WO-2021101133-A1 Method for preparing yolk antibodies for preventing or treating salmonid rickettsial septicaemia Inactive 18-Nov-2019
WO-2021100993-A1 Method for producing yolk antibody for prevention or treatment of obesity through cholesterol absorption inhibition Inactive 18-Nov-2019 C07K16/18
To view Adbiotech’s complete patent history, request access »

Adbiotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adbiotech Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
A-Stone Ventures Venture Capital Minority
HB Investment Venture Capital Minority
ID Ventures (South Korea) Venture Capital Minority
Magna Investment (Seoul) Venture Capital Minority
SBI Investment Korea Company PE-Backed Company Minority
You’re viewing 5 of 7 investors. Get the full list »

Adbiotech Investments (3)

Adbiotech’s most recent deal was a Later Stage VC with Onheal for . The deal was made on 06-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Onheal 06-Jul-2026 Later Stage VC Other Services (B2C Non-Financial)
Wiju 17-Jan-2023 Later Stage VC Business/Productivity Software
Immunotherapeutic Products (AD Biotech / Quest PharmaTech) 23-Jul-2013 Joint Venture Therapeutic Devices
To view Adbiotech’s complete investments history, request access »

Ready to get started?

Request a free trial

Adbiotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Adbiotech’s complete esg history, request access »

Adbiotech FAQs

  • When was Adbiotech founded?

    Adbiotech was founded in 2000.

  • Where is Adbiotech headquartered?

    Adbiotech is headquartered in Chuncheon, South Korea.

  • What is the size of Adbiotech?

    Adbiotech has 60 total employees.

  • What industry is Adbiotech in?

    Adbiotech’s primary industry is Drug Discovery.

  • Is Adbiotech a private or public company?

    Adbiotech is a Private company.

  • What is Adbiotech’s current revenue?

    The current revenue for Adbiotech is .

  • How much funding has Adbiotech raised over time?

    Adbiotech has raised $18.9M.

  • Who are Adbiotech’s investors?

    A-Stone Ventures, HB Investment, ID Ventures (South Korea), Magna Investment (Seoul), and SBI Investment Korea Company are 5 of 7 investors who have invested in Adbiotech.

  • When was Adbiotech acquired?

    Adbiotech was acquired on 04-Jun-2026.

  • Who acquired Adbiotech?

    Adbiotech was acquired by OQ BioM.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process